American Bio Medica Corporation
ABMC
$0.00
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 397.20% | -204.54% | -282.21% | 64.75% | 72.15% |
| Total Depreciation and Amortization | -26.98% | -25.00% | -26.39% | -21.62% | -18.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -942.03% | 70.10% | 193.59% | -196.85% | -166.77% |
| Change in Net Operating Assets | 38.83% | 442.54% | 1,159.46% | 24,400.00% | 116.80% |
| Cash from Operations | -241.90% | -14.12% | 100.29% | 85.23% | 74.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -29.11% | -34.49% | -45.14% | -44.38% | -46.09% |
| Total Debt Repaid | 66.23% | 47.88% | 13.35% | 30.51% | 40.25% |
| Issuance of Common Stock | -- | -- | 185.71% | 185.71% | 185.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 228.11% | -0.43% | -103.41% | -85.20% | -62.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 210.87% | -576.47% | -55.00% | 85.64% | 91.12% |